Find the latest news about ACS DOBFAR SPA aggregated by PharmaCompass.com.

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formulations (Solid and Injectable). We export our products to MORE than 100 countries all over the world. Our production sites, most of them regularly inspected by EUROPEN AND USA AUTHORITIES (FDA), have strict Quality Standards and our R&D Know-how ma...
We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formulations (Solid and Injectable). We export our products to MORE than 100 countries all over the world. Our production sites, most of them regularly inspected by EUROPEN AND USA AUTHORITIES (FDA), have strict Quality Standards and our R&D Know-how make us a leading company. Our Commitment: to work in the present while concentrating on the future, because on markets where research and technology are factors of primary importance.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Viale Addetta 4/12 20067 Tribiano (Milan)
Telephone
Telephone
+39-029-069-31
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

CPhI Worldwide, Milan

CPhI Worldwide, Milan

Not Confirmed

envelop Contact Supplier

CPhI Worldwide, Milan

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1891

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
BMS, Bayer, Takeda, Pfizer downsize to combat cost pressures, meet restructuring plans
Over the last two years, there has been a significant surge in layoffs by pharmaceutical and biotech companies. The trend spilled over to 2024. Data compiled by PharmaCompass indicates that between January and early-September, around 150 companies had implemented layoffs. Bristol Myers Squibb (BMS) tops the list of companies that downsized, with a staggering 2,284 job cuts. Bayer stood second at 1,816 retrenchments, followed by Takeda Pharmaceuticals at 1,155. Johnson & Johnson’s spin-off Kenvue is slashing over 1,000 jobs this year, while Roche subsidiary Genentech is cutting 529 positions, and Novartis is going ahead with its multi-year restructuring, and cutting another 770 jobs. One of the primary drivers of layoffs has been the need for companies to streamline operations and reduce costs. Many firms have faced financial pressures due to reasons such as declining revenues, increased competition, and the high costs associated with drug development. The current wave of layoffs has encompassed geographies – from traditional pharma strongholds like New Jersey, biotech hubs in Massachusetts and California, to Europe (particularly Germany and Switzerland). This is not to suggest that job cuts are a norm. Certain segments have been experiencing substantial growth and job creation. This includes companies like Eli Lilly and Novo Nordisk that have experienced remarkable growth due to the efficacy of their glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs that treats type 2 diabetes and obesity.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 as of Sept. 7 (Free Excel Available) BMS cuts 2,284 jobs to meet cost targets, Bayer hands pink slips to 1,816 employees Several large drugmakers have announced job cuts this year in order to meet their cost cutting goals, or as part of their restructuring exercise. BMS’ revenue had declined from US$ 46.2 billion in 2022 to US$ 45 billion in 2023. The financial pressure has compelled it to cut 2,284 jobs so far in this year, a move that sent shockwaves through the industry. Overall, BMS hopes to save approximately US$ 1.5 billion in costs by 2025 through this “strategic productivity initiative”. In Europe, Swiss-based companies like Novartis and Roche have announced substantial job cuts, while Bayer is reducing its workforce globally.  Bayer is laying off 1,816 employees worldwide, including 150 in Basel, Switzerland. A majority of these are management roles as the German drugmaker seeks to target € 500 million (US$ 557 million) in cost savings in 2024 and € 2 billion (US$ 2.23 billion) in 2026. Japanese drugmaker Takeda plans to eliminate 1,155 positions, including 324 jobs in San Diego and 641 in Massachusetts. Takeda is also winding down production and R&D operations in Austria, resulting in 190 job losses. Starting next month, Genentech, a Roche subsidiary, will lay off 93 employees in San Francisco. Earlier this year, Genentech trimmed roughly 3 percent of its workforce across several departments, impacting 436 employees. Roche also laid off around 340 employees in its product development team. Novartis has been undergoing a significant restructuring exercise since 2022, when it announced 8,000 job cuts in its global workforce. This year, it announced an additional 770 job cuts in its product development organization, separate from the previous reductions. Once again, it was workforces in Switzerland (440 job cuts) and US (269 job cuts) that bore the brunt. Tylenol and Band-Aid maker Kenvue, which spun off from J&J last year, announced plans to cut 920 jobs, representing about 4 percent of its global workforce. Additionally, the company will lay off 51 employees in New Jersey and 84 in California. These layoffs are part of Kenvue’s efforts to adjust its cost structure and become more competitive.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 as of Sept. 7 (Free Excel Available)  Perrigo, Emergent Bio, Catalent, BioMarin trim workforces amid strategic shifts Several mid-size companies too are under tremendous cost pressures, with some of them feeling the need to reinvent themselves for the future. In February this year, Perrigo had embarked on ‘Project Energize’, a three-year initiative aimed at boosting organizational agility and achieving long-term success. As part of this project, Perrigo is cutting costs and laying off 6 percent of its staff, which translates into nearly 550 employees. CDMO-turned-biopharma Emergent BioSolutions plans to reduce its workforce by about 300 employees. The Maryland-based multinational is closing its Baltimore-Bayview drug substance manufacturing facility and its Rockville drug product facility in the state. Rare disease biotech BioMarin laid off 395 employees globally, about 12 percent of its workforce, as part of “organizational redesign efforts” to prioritize its new strategy with its hemophilia A gene therapy Roctavian and to preserve cash. Drug-delivery specialist Catalent has also been significantly impacted by restructuring efforts ever since it announced 1,100 layoffs in December. It had then attributed its fall in revenue to declining Covid-related sales, but had also noted that future GLP-1 manufacturing revenues could help stabilize its finances. True enough — it subsequently announced that it is in the process of being acquired by Novo Nordisk’s parent company for US$ 16.5 billion. However, Catalent reported reducing its headcount by an additional 300 in the fourth quarter of 2023.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 as of Sept. 7 (Free Excel Available)  Pfizer job cuts continue to trickle in; Lykos, Lyra downsize after pipeline setbacks Clinical trial failures and financial constraints have also played a significant role in this year’s wave of layoffs. At Pfizer, job cuts continued to trickle in, with some estimates putting the number at 1,500 employees in 2024. These include 285 at its vaccine R&D site in New York, and 52 in San Francisco. The Comirnaty maker also pulled the plug on a long-anticipated, near-complete Seagen drug manufacturing plant in Everett, Washington. About 120 employees at the site were let go.  It has been a tumultuous time for Lykos Therapeutics, following the US Food and Drug Administration’s rejection of its MDMA-assisted therapy for post-traumatic stress disorder. Lykos announced laying off 75 percent of its staff (i.e. 75 employees). Its founder, who had spent 38 years working on the therapy, left the company and so did its CEO. However, Lykos has not given up and has roped in a Janssen veteran as senior medical advisor to get the therapy past the finish line. Similarly, Lyra Therapeutics is laying off 75 percent of its workforce (i.e. 87 employees) following disappointing late-stage results for its implant to treat chronic rhino-sinusitis. The retrenchments include its chief technology officer.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 as of Sept. 7 (Free Excel Available)  Our view Technology, regulatory and pricing pressures are shaping strategies of pharmaceutical companies. The drive to do more with less could accelerate the adoption of artificial intelligence, machine learning, and automation in drug discovery and development processes. The employment landscape is certainly evolving. We foresee significant changes in the skills required for pharmaceutical and biotech careers, with a growing emphasis on data science and computational biology.

Impressions: 720

https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans

#PharmaFlow by PHARMACOMPASS
19 Sep 2024

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065441

FDA
03 Jan 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205043

FDA
31 Oct 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208790

FDA
19 Apr 2018

http://www.pharmamanufacturing.com/industrynews/2017/fda-cites-three-pharma-five-medical-device-companies/

PHARMA MANUFACTURING
01 Feb 2017

https://www.pharmacompass.com/pdf/news/facta-farmaceutici-receives-fda-warning-letter-1485923976.pdf

FDA
13 Jan 2017

01

Ampicillin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Ampicillin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

02

Cefaclor

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cefaclor

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

03

Cefazolin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cefazolin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

04

Ceftazidime

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Ceftazidime

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

05

Amikacin Sulfate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Amikacin Sulfate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Cefotaxime

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cefotaxime

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Ceftriaxone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Ceftriaxone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Cefuroxime Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cefuroxime Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

09

Cephalexin Monohydrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cephalexin Monohydrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Cephalexin Monohydrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

Cephalexin Monohydrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

04

BioProcess International
Not Confirmed
arrow

10

BioProcess International
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : ACETAMINOPHEN

BioProcess International
Not Confirmed
arrow

Brand Name : ACETAMINOPHEN

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : SOLUTION;INTRAVENOUS

Brand Name : ACETAMINOPHEN

Dosage Strength : 1GM/100ML (10MG/ML)

Packaging :

Approval Date : 2023-05-03

Application Number : 215403

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : AMPICILLIN SODIUM

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN SODIUM

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN SODIUM

Dosage Strength : EQ 1GM BASE/VIAL

Packaging :

Approval Date : 2013-04-03

Application Number : 90884

Regulatory Info : DISCN

Registration Country : USA

blank

03

Brand Name : AMPICILLIN SODIUM

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN SODIUM

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN SODIUM

Dosage Strength : EQ 10GM BASE/VIAL

Packaging :

Approval Date : 2013-04-03

Application Number : 90889

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : AMPICILLIN SODIUM

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN SODIUM

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN SODIUM

Dosage Strength : EQ 500MG BASE/VIAL

Packaging :

Approval Date : 2013-04-03

Application Number : 90884

Regulatory Info : DISCN

Registration Country : USA

blank

05

Brand Name : AMPICILLIN SODIUM

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN SODIUM

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN SODIUM

Dosage Strength : EQ 2GM BASE/VIAL

Packaging :

Approval Date : 2013-04-03

Application Number : 90884

Regulatory Info : DISCN

Registration Country : USA

blank

06

Brand Name : AMPICILLIN AND SULBA...

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN AND SULBA...

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN AND SULBACTAM

Dosage Strength : EQ 1GM BASE/VIAL;EQ 50...

Packaging :

Approval Date : 2009-12-22

Application Number : 65406

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : AMPICILLIN AND SULBA...

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN AND SULBA...

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN AND SULBACTAM

Dosage Strength : EQ 10GM BASE/VIAL;EQ 5...

Packaging :

Approval Date : 2009-12-23

Application Number : 65403

Regulatory Info : RX

Registration Country : USA

blank

08

Brand Name : AMPICILLIN AND SULBA...

BioProcess International
Not Confirmed
arrow

Brand Name : AMPICILLIN AND SULBA...

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : INJECTABLE;INJECTION

Brand Name : AMPICILLIN AND SULBACTAM

Dosage Strength : EQ 2GM BASE/VIAL;EQ 1G...

Packaging :

Approval Date : 2009-12-22

Application Number : 65406

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : N/A

BioProcess International
Not Confirmed
arrow

Brand Name : N/A

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : Capsules

Brand Name :

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

Brand Name : CEFACLOR

BioProcess International
Not Confirmed
arrow

Brand Name : CEFACLOR

arrow
BioProcess International
Not Confirmed

ACS DOBFAR SPA

Dosage Form : FOR SUSPENSION;ORAL

Brand Name : CEFACLOR

Dosage Strength : EQ 250MG BASE/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 62206

Regulatory Info : DISCN

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

Inspections and registrations

Upload your audits for free, ask us

GDUFA

read-more
read-more

01

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer :

FDF Manufacturer :

Facility Name : ACS DOBFAR SpA - ADDETTA SITE

Business Address : VIALE ADDETTA 2a/12 - 3/5 TR...

FEI Number : 3002806297

Country : Italy

Paid in : 2019

blank

02

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : ACS DOBFAR SpA - ALBANO SITE

Business Address : VIA TONALE 87 ALBANO SANT'AL...

FEI Number : 3002806293

Country : Italy

Paid in : 2019

blank

03

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : ACS DOBFAR SpA - ROSSINI SITE

Business Address : VIA ROSSINI 7/9/11 TRIBIANO ...

FEI Number : 3002806298

Country : Italy

Paid in : 2019

blank

04

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : ACS DOBFAR SpA - VIMERCATE SIT...

Business Address : VIA MARZABOTTO 1, 7/9 VIMERC...

FEI Number : 3002806299

Country : Italy

Paid in : 2019

blank

05

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer : API MANUFACTURE

FDF Manufacturer : FDF MANUFACTURE

Facility Name : Antibioticos do Brasil Ltda. (...

Business Address : Rod Professor Zeferino Vaz, ...

FEI Number : 3004132818

Country : Brazil

Paid in : 2019

blank

06

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer :

FDF Manufacturer : FDF MANUFACTURE

Facility Name : FACTA FARMACEUTICI SpA

Business Address : ZONA INDUSTRIALE SANT'ATTO S...

FEI Number : 3006028606

Country : Italy

Paid in : 2019

blank

07

GDUFA fees paid

USA
BioProcess International
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
BioProcess International
Not Confirmed

API Manufacturer :

FDF Manufacturer : FDF MANUFACTURE

Facility Name : InfoRLife SA

Business Address : Casai Campascio GR 7748 Swit...

FEI Number : 3004537783

Country : Italy

Paid in : 2019

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact ACS DOBFAR SPA and get a quotation

ACS DOBFAR SPA is a supplier offers 133 products (APIs, Excipients or Intermediates).

Find a price of Ampicillin Sodium bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

Find a price of Cefaclor bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

Find a price of Cefazolin Sodium bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

Find a price of Ceftazidime bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

Find a price of Amikacin Sulfate bulk with DMF, JDMF offered by ACS DOBFAR SPA

Find a price of Cefaclor bulk with CEP, JDMF offered by ACS DOBFAR SPA

Find a price of Cefepime bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Cefotaxime bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Ceftriaxone bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Cephalexin Monohydrate bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Cilastatin Sodium bulk with DMF, JDMF offered by ACS DOBFAR SPA

Find a price of Clindamycin Phosphate bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Meropenem bulk with DMF, CEP offered by ACS DOBFAR SPA

Find a price of Sulbactam Sodium bulk with DMF, JDMF offered by ACS DOBFAR SPA

Find a price of Clindamycin Hydrochloride bulk with CEP offered by ACS DOBFAR SPA

Find a price of 6-Aminopenicillanic Acid bulk with DMF offered by ACS DOBFAR SPA

Find a price of 7-Amino-3-[(5-Methyl-1,3,4-Thiadiazol-2-Yl)Thiomethyl]Cephalosphoranic Acid bulk with DMF offered by ACS DOBFAR SPA

Find a price of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid bulk with DMF offered by ACS DOBFAR SPA

Find a price of Amikacin bulk with DMF offered by ACS DOBFAR SPA

Find a price of Amoxicillin Sodium bulk with CEP offered by ACS DOBFAR SPA

Find a price of Amoxicillin Trihydrate bulk with DMF offered by ACS DOBFAR SPA

Find a price of Ampicillin Sodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Ampicillin Trihydrate bulk with DMF offered by ACS DOBFAR SPA

Find a price of Carbopol 940 API bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefadroxil bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefadroxil Monohydrate bulk with CEP offered by ACS DOBFAR SPA

Find a price of Cefalotin sodium Sterile bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefazolin bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefepime Hydrochloride bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefoperazone Sodium bulk with JDMF offered by ACS DOBFAR SPA

Find a price of Cefotaxime bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefotetan bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefotetan Disodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefoxitin bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefoxitin Sodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Ceftaroline Fosamil bulk with DMF offered by ACS DOBFAR SPA

Find a price of Ceftazidime bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cefuroxime Axetil bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cephalexin bulk with JDMF offered by ACS DOBFAR SPA

Find a price of Cephapirin bulk with DMF offered by ACS DOBFAR SPA

Find a price of Cephapirin Sodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Ertapenem Sodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Gentamicin Sulfate bulk with DMF offered by ACS DOBFAR SPA

Find a price of Imipenem bulk with DMF offered by ACS DOBFAR SPA

Find a price of L-Arginine bulk with DMF offered by ACS DOBFAR SPA

Find a price of Meropenem bulk with DMF offered by ACS DOBFAR SPA

Find a price of Mono Propylene Glycol bulk with JDMF offered by ACS DOBFAR SPA

Find a price of Nafcillin Sodium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Penicillin G Potassium bulk with DMF offered by ACS DOBFAR SPA

Find a price of Piperacillin + Tazobactam bulk with DMF offered by ACS DOBFAR SPA

Find a price of Sodium Bicarbonate bulk with DMF offered by ACS DOBFAR SPA

Find a price of Sodium Carbonate bulk with DMF offered by ACS DOBFAR SPA

Find a price of Trisodium Citrate Dihydrate bulk with DMF offered by ACS DOBFAR SPA

Find a price of DEFU (DECARBAMOYLCEFUROXINE) bulk with DMF offered by ACS DOBFAR SPA

Find a price of 6-Aminopenicillanic Acid bulk offered by ACS DOBFAR SPA

Find a price of 7-Aminodesacetoxycephalosporanic Acid bulk offered by ACS DOBFAR SPA

Find a price of Amikacin Sulfate bulk offered by ACS DOBFAR SPA

Find a price of Beclomethasone Dipropionate bulk offered by ACS DOBFAR SPA

Find a price of Benzyl Penicillin bulk offered by ACS DOBFAR SPA

Find a price of Betamethasone bulk offered by ACS DOBFAR SPA

Find a price of Betamethasone Sodium Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Betamethasone Valerate bulk offered by ACS DOBFAR SPA

Find a price of Bombesin Tyr4 bulk offered by ACS DOBFAR SPA

Find a price of Cabergoline bulk offered by ACS DOBFAR SPA

Find a price of Carbopol 940 API bulk offered by ACS DOBFAR SPA

Find a price of Cefadroxil bulk offered by ACS DOBFAR SPA

Find a price of Cefalotin sodium Sterile bulk offered by ACS DOBFAR SPA

Find a price of Cefamandole Nafate bulk offered by ACS DOBFAR SPA

Find a price of Cefazolin bulk offered by ACS DOBFAR SPA

Find a price of Cefazolin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Cefoxitin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Cefprozil bulk offered by ACS DOBFAR SPA

Find a price of Ceftriaxone bulk offered by ACS DOBFAR SPA

Find a price of Cephradine bulk offered by ACS DOBFAR SPA

Find a price of Clindamycin Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Cloxacillin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Desonide bulk offered by ACS DOBFAR SPA

Find a price of Dexamethasone bulk offered by ACS DOBFAR SPA

Find a price of Dexamethasone Sodium Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Disodium Hydrogen Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Endrysone bulk offered by ACS DOBFAR SPA

Find a price of Ethanol bulk offered by ACS DOBFAR SPA

Find a price of Flucloxacillin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Flumethasone bulk offered by ACS DOBFAR SPA

Find a price of Flumethasone Pivalate bulk offered by ACS DOBFAR SPA

Find a price of Fluocinolone Acetonide bulk offered by ACS DOBFAR SPA

Find a price of Fluocinonide bulk offered by ACS DOBFAR SPA

Find a price of Fluorometholone bulk offered by ACS DOBFAR SPA

Find a price of Fluorometholone Acetate bulk offered by ACS DOBFAR SPA

Find a price of Flurandrenolone bulk offered by ACS DOBFAR SPA

Find a price of Hydrocortisone Sodium Succinate bulk offered by ACS DOBFAR SPA

Find a price of Hydroxyprogesterone Caproate bulk offered by ACS DOBFAR SPA

Find a price of Ibuprofen bulk offered by ACS DOBFAR SPA

Find a price of Medroxyprogesterone Acetate bulk offered by ACS DOBFAR SPA

Find a price of Medrysone bulk offered by ACS DOBFAR SPA

Find a price of Methyldopa bulk offered by ACS DOBFAR SPA

Find a price of Methylprednisolone Acetate bulk offered by ACS DOBFAR SPA

Find a price of Methylprednisolone Hemisuccinate bulk offered by ACS DOBFAR SPA

Find a price of Nafcillin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Oxacillin Sodium bulk offered by ACS DOBFAR SPA

Find a price of Penicillin G Potassium bulk offered by ACS DOBFAR SPA

Find a price of Prednisolone Sodium Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Progesterone bulk offered by ACS DOBFAR SPA

Find a price of Sodium Carbonate bulk offered by ACS DOBFAR SPA

Find a price of Spironolactone bulk offered by ACS DOBFAR SPA

Find a price of Tacrolimus bulk offered by ACS DOBFAR SPA

Find a price of Tetracycline Phosphate bulk offered by ACS DOBFAR SPA

Find a price of Triamcinolone bulk offered by ACS DOBFAR SPA

Find a price of Triamcinolone Acetonide bulk offered by ACS DOBFAR SPA

Find a price of Triamcinolone Diacetate bulk offered by ACS DOBFAR SPA

Find a price of Triprolidine Hydrochloride bulk offered by ACS DOBFAR SPA

Find a price of Vancomycin Hydrochloride bulk offered by ACS DOBFAR SPA

Find a price of FACILITY AND OPERATING PROCEDURES IN VIA MARZABOTTO, VIMERCATE, MILANO, ITALY (PREVIOUSLY AN ANTIBIOTIC FILE) bulk offered by ACS DOBFAR SPA

Find a price of THYMIC HUMORAL FACTOR GAMMA 2 FINISHED DOSAGE, MILAN ITALY bulk offered by ACS DOBFAR SPA

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN RODANO, ITALY. bulk offered by ACS DOBFAR SPA

Find a price of CEFUROXIME bulk offered by ACS DOBFAR SPA

Find a price of THYMIC HUMORAL FACTOR GAMMA 2 ACTIVE DRUG SUBS. - MILAN,ITALY bulk offered by ACS DOBFAR SPA

Find a price of PERSONNEL, FACILITIES AND GENERAL OPERATING PROCEDURES bulk offered by ACS DOBFAR SPA

Find a price of MANUFACTURING FACILITIES, PERSONNEL, AND GENERAL OPERATIONS IN BERGAMO, ITALY bulk offered by ACS DOBFAR SPA

Find a price of O-FORMYL CEFAMANDOLE ACETONITRILE SOLVATE bulk offered by ACS DOBFAR SPA

Find a price of CHEM. & PHARMACY OF ANTIBIOTIC LM 427 AS IT WILL BE REFERENCED BY INDS bulk offered by ACS DOBFAR SPA

Find a price of FACILITIES AND CONTROLS bulk offered by ACS DOBFAR SPA

Find a price of Amphotericin B bulk offered by ACS DOBFAR SPA

Find a price of Ampicillin bulk offered by ACS DOBFAR SPA

Find a price of Biapenem bulk offered by ACS DOBFAR SPA

Find a price of Cefixime bulk offered by ACS DOBFAR SPA

Find a price of Cephapirin Benzathine bulk offered by ACS DOBFAR SPA

Find a price of Cephradine Monohydrate bulk offered by ACS DOBFAR SPA

Find a price of Cloxacillin Benzathine bulk offered by ACS DOBFAR SPA

Find a price of Doripenem bulk offered by ACS DOBFAR SPA

Find a price of Nafcillin bulk offered by ACS DOBFAR SPA

Find a price of Piperacillin Sodium bulk offered by ACS DOBFAR SPA

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty